Jaime Hatcher-Martin, MD, PhD, a movement disorders specialist at Emory University Hospital and the founder of Emory's movement disorders telemedicine clinic, shares her personal experience with telemedicine and provides some guidance for clinicians who might be interested in exploring this treatment option to improve their patients' access to care. Scroll below the video to read the full transcript.
Kara Smith, MD, a movement disorders specialist at UMass Memorial Medical Center and an assistant professor at the University of Massachusetts Medical School, both in Worcester, discusses how a brief free speech sample might be used to calculate a patient's cognitive and motor scores. Scroll below the video to read the full transcript.
Nearly 40% of patients in the treatment group were "much" or "very much" improved at 4 weeks.
Patients who underwent deep brain stimulation were 94% less likely to require polypharmacy at 5 years.
Although nonmotor symptoms in Parkinson's have gained significant attention through the years, blood pressure changes have been overlooked.
Patients with metabolic syndrome experienced greater worsening of UPDRS scores over time compared with patients without metabolic syndrome.
Analyses of the ARM-TD and AIM-TD trials indicate that deutetrabenazine performs better than placebo as treatment for tardive dyskinesia.
Four-year results show that motor complications, but not burden of nonmotor symptoms, can predict death in patients with Parkinson's disease.
Previous research has shown that plasma neurofilament light chain concentration may predict severity of disease progression in progressive supranuclear palsy.
New research suggests that baseline gut microbiota may predict the progression of Parkinson's disease at 2 years.
While polyneuropathy is fairly common in Parkinson's disease, the etiology of the pain condition is not clear.
Researchers sought to better understand the potential role of cholesterol in the etiology of Parkinson's disease.
Learn more about what to expect from this year's International Congress of Parkinson's Disease and Movement Disorders.
Neurology Advisor Articles
- OCD in Duchenne Muscular Dystrophy Features Distinct Phenotype, Associated Symptoms
- History of Migraine Associated With Higher Risk for Cochlear Disorders
- Patent Foramen Ovale Closure for Stroke Prevention: Key Principles for Clinical Practice
- Vagus Nerve Stimulation in Pediatric Epilepsy: Weighing the Risks and Benefits
- A Model for Predicting Quality of Life Improvements After Deep Brain Stimulation
- Some Statins May Be Associated With Cognition, Memory Deficits
- Neuropathic Pain Treatments
- Cannabis for Multiple Sclerosis: Prescriber's Perspective
- New Monoclonal Antibody BAN2401 Reduces Amyloid Plaques, Improves Cognition in Alzheimer's
- Nonpharmacologic Interventions for Alzheimer's Have Greater Impact on Outcomes Than Currently Available Medications
- Population-Based Incidence of Acute Idiopathic Optic Neuritis Estimated
- First-in-Class Therapy Approved for Polyneuropathy Caused by hATTR
- High Anxiety Symptoms Prevalent in Epilepsy, Mesial Temporal Sclerosis
- Advance Care Planning Doesn't Aid Quality of Life
- Variation in Specialty Drug Coverage Across Health Plans